Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novacare (NOV) breaking out... -- Ignore unavailable to you. Want to Upgrade?

To: puborectalis who wrote (367)	2/7/1999 10:34:00 PM
From: Jim Oravetz	Read Replies (2) \| Respond to of 420

NOV has a "cloudy" earning forecast for at least 6-9 months with some debt that must be paid off. Given those factors, it looks like $ losses are a real possibility. Is that enough to justify the low price? That is the $64K question. IMHO, there is not much more downside risk that can be gotten out of this. Long term, NOV has some solid businesses that are #2 in the country (in terms of revenue?) They had over $1B in total revenue not too long ago. There has been talk of selling some divisions but this has been recanted by recent comments from NOV mngt. Long term it is attractive to me at these prices. DO YOUR OWN HOMEWORK AND PROFIT! For what it's worth, the Yahoo thread seems to have some good info on NOV if you can stand the peripheral chatter. PS Watch out for the bottom when INTC starts to fall. Jim